MercadoLibre, Inc. (MELI)
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
$1978.36-0.64%
Close 2026-09-04 · 1-day change
NASDAQConsumer DiscretionarySpecialty RetailSnapshot 2026-09-04
Research Workspace
Put MELI beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Operating income recovers or stays near $611M in 2026-Q1: Op income $611M vs $611M target.
View ThesisRevenue growth is accelerating — up about 46% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 23%.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMercadoLibre's growth in revenue must continue to justify its current valuation. Revenue increased 50% year-over-year to $19 billion in H1 2026, despite a 13% decline in net income. It trades at 54× P/E versus a peer median of 15×, indicating that expectations look modest compared to our view. If MELI cuts guidance on the next call, that could negatively impact its stock. Peer multiples imply a price about 18% above where it trades. Our read is provisional.
Trailing returns as of 2026-09-04. MELI is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 24 analysts currently covering MELI (as of Sep 2026).
Based on 8 Wall Street analysts offering 12-month price targets for MELI in the last 4 months.
Continue this research
Compare MELI with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MELI Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Broadline Retail — fair value, gap to price, and forward P/E.
Compare the value case
Put MELI next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand revenue growth
Growth acceleration supports revenue expansion objective.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $1978.36
The last 12 months of price, then the range of analyst 12-month targets from today’s $1978.36.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Increase operating income
Margin pressure could hinder operating income growth.
Advances: Expand revenue growth
Long-term growth potential supports revenue objectives.
Threatens: Increase operating income
Earnings miss raises concerns about income growth.
Threatens: Increase operating income
Target cut indicates margin reset concerns.